Universal Beteiligungs und Servicegesellschaft mbH Makes New $1.04 Million Investment in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH invested $1.04 million in Alignment Healthcare, acquiring 56,085 shares valued at approximately $1,044,000 during the 1st quarter.
• Alignment Healthcare reported $1.02 billion in revenue for the last quarter, surpassing analysts' expectations, with a year-over-year revenue increase of 49.0%.
• Analysts have set new price targets for Alignment Healthcare, with several upgrades; Stifel Nicolaus increased its target from $18.00 to $23.00 and maintained a "buy" rating.

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 56,085 shares of the company's stock, valued at approximately $1,044,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Wellington Management Group LLP raised its stake in shares of Alignment Healthcare by 77.9% during the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock valued at $83,683,000 after acquiring an additional 3,257,630 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in Alignment Healthcare by 54.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock valued at $97,302,000 after buying an additional 3,059,596 shares during the period. Millennium Management LLC increased its holdings in Alignment Healthcare by 588.3% during the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after buying an additional 2,896,311 shares during the period. Point72 Asset Management L.P. purchased a new position in Alignment Healthcare during the fourth quarter valued at approximately $20,087,000. Finally, Broad Bay Capital Management LP purchased a new position in Alignment Healthcare during the fourth quarter valued at approximately $18,804,000. Institutional investors own 86.19% of the company's stock.

Alignment Healthcare Stock Performance

Alignment Healthcare stock traded up $0.26 during midday trading on Wednesday, hitting $13.67. 929,941 shares of the company's stock were exchanged, compared to its average volume of 3,016,963. Alignment Healthcare, Inc. has a 12-month low of $8.17 and a 12-month high of $21.06. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market cap of $2.71 billion, a price-to-earnings ratio of -48.87 and a beta of 1.16. The firm's 50 day simple moving average is $13.84 and its 200 day simple moving average is $15.32.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business's quarterly revenue was up 49.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.13) earnings per share. Equities research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ALHC. UBS Group lifted their price target on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Wall Street Zen raised shares of Alignment Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Robert W. Baird boosted their price objective on shares of Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a report on Tuesday, April 15th. Finally, Stifel Nicolaus boosted their price objective on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a report on Tuesday, April 8th. Four analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $17.61.

Insiders Place Their Bets

In other news, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $13.44, for a total value of $403,200.00. Following the sale, the president owned 2,042,899 shares of the company's stock, valued at $27,456,562.56. The trade was a 1.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Andreas P. Wagner sold 19,399 shares of the business's stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $15.26, for a total transaction of $296,028.74. Following the sale, the insider directly owned 204,075 shares in the company, valued at approximately $3,114,184.50. This represents a 8.68% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,700,753 shares of company stock valued at $269,911,757. Corporate insiders own 6.60% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.